Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin

Acta Diabetologica

Volumn 52, Issue 2, 2014, Pages 383-393

  Biemans, Elke ^a   Hart, Huberta E ^a,b   Rutten, Guy E H M ^a   Cuellar Renteria, Viviana G ^a   Kooijman Buiting, Antoinette M J ^c   Beulens, Joline W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Leidsche Rijn Julius Health Care Centers   (Netherlands)

^c SALTRO   (Netherlands)

Author keywords

Cognition; Depression; Metformin; Neuropathy; Type 2 diabetes; Vitamin B12 deficiency

Indexed keywords

CYANOCOBALAMIN; METFORMIN;

ADULT; AGED; COGNITION; COMPLICATION; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMAN; MALE; METABOLISM; PSYCHOLOGY; VITAMIN B 12 DEFICIENCY;

ADULT; AGED; COGNITION; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; METFORMIN; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 84939951430     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0661-4     Document Type: Article

References (32)

1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD) (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364–1379
2. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V (2000) Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care 23:1227–1231
3. Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM (2006) Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med 166:1975–1979
4. Kibirige D, Mwebaze R (2013) Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified? J Diabetes Metab Disord 12(1):17
5. Oh R, Brown DL (2003) Vitamin B12 deficiency. Am Fam Physician 67:979–986
6. Penninx BWJH, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP (2000) Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the women’s health and aging study. Am J Psychiatry 157:715–721
7. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM (2002) Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 159:2099–2101
8. Hin H, Clarke R, Sherliker P, Atoyebi W, Emmens K, Birks J, Schneede J, Ueland PM, Nexo E, Scott J, Molloy A, Donaghy M, Frost C, Evans JG (2006) Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. Age Ageing 35:416–422
9. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J (1991) Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 70:229–245
10. Wile DJ, Toth C (2010) Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care 33:156–161
11. Ambrosch A, Dierkes J, Lobmann R, Kuhne W, Konig W, Luley C, Lehnert H (2001) Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabetes Med 18:185–192
12. Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, Woodward M, Boundy K, Ellis KA, Bush AI, Faux NG, Martins R, Szoeke C, Rowe C, Watters DA, AIBL Investigators (2013) Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 36:2981–2987
13. Beulens JW, Hart HE, Kuijs R, Kooijman-Buiting AM, Rutten GE (2014) Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol [Epub ahead of print]
14. Lamberts H, Wood M (eds) (1987) ICPC. International Classification of Primary Care. Oxford University Press, Oxford
15. Balen V (2009) Landelijke transmurale afspraak chronische nierschade. Huisarts Wet 52:586–597
16. WHO (1998) Wellbeing Measures in Health Care: The Depcare Project: Report on a WHO Meeting Stockholm, Sweden 12–13 February 1998. København: World Health Organization Regional Office for Europe
17. Hermanns N, Kulzer B, Krichbaum M, Kubiak T, Haak T (2006) How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 49:469–477
18. Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
19. Brown J, Pengas G, Dawson K, Brown LA, Clatworthy P (2009) Self administered cognitive screening test (TYM) for detection of Alzheimer’s disease: cross sectional study. BMJ 338:b2030
20. Koekkoek PS, Rutten GE, van den Berg E, van Sonsbeek S, Gorter KJ, Kappelle LJ, Biessels GJ (2013) The “Test Your Memory” test performs better than the MMSE in a population without known cognitive dysfunction. J Neurol Sci 328:92–97
21. Feng Y, Schlosser FJ, Sumpio BE (2009) The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 50:675–682
22. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289
23. Yetley EA, Pfeiffer CM, Phinney KW, Bailey RL, Blackmore S, Bock JL, Brody LC, Carmel R, Curtin LR, Durazo-Arvizu RA, Eckfeldt JH, Green R, Gregory JF III, AN Hoofnagle, Jacobsen DW, Jacques PF, Lacher DA, Molloy AM, Massaro J, Mills JL, Nexo E, Rader JI, Selhub J, Sempos C, Shane B, Stabler S, Stover P, Tamura T, Tedstone A, Thorpe SJ, Coates PM, Johnson CL, Picciano MF (2011) Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr 94:313S–321S
24. Stabler SP (2013) Clinical practice. Vitamin B12 deficiency. N Engl J Med 368:149–160
25. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr (2012) Association of biochemical B(1)(2) deficiency with metformin therapy and vitamin B(1)(2) supplements: the National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care 35:327–333
26. Heil SG, de Jonge R, de Rotte MC, van Wijnen M, Heiner-Fokkema RM, Kobold AC, Pekelharing JM, Adriaansen HJ, Sanders E, Trienekens PH, Rammeloo T, Lindemans J (2012) Screening for metabolic vitamin B12 deficiency by holotranscobalamin in patients suspected of vitamin B12 deficiency: a multicentre study. Ann Clin Biochem 49:184–189
27. Verweij A. (2008) Scholing en opleiding: Indeling opleidingsniveau. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. Bilthoven: RIVM, www.nationaalkompas.nl Nationaal Kompas Volksgezondheid\Bevolking\Scholing en opleiding
28. McCracken C, Hudson P, Ellis R, McCaddon A (2006) Methylmalonic acid and cognitive function in the medical research council cognitive function and ageing study. Am J Clin Nutr 84:1406–1411
29. Chen S, Lansdown AJ, Moat SJ, Ellis R, Goringe A, Dunstan FD, Rees JAE (2012) An observational study of the effect of metformin on B12 status and peripheral neuropathy. Br J Diabetes Vasc Dis 12:189–193
30. Nexo E, Hoffmann-Lucke E (2011) Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 94:359S–365S
31. Hvas AM, Nexo E (2006) Diagnosis and treatment of vitamin B12 deficiency—an update. Haematologica 91:1506–1512
32. Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A (2011) Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care 34:2244–2249